TY - JOUR
T1 - O-RADS US risk stratification and management system
T2 - A consensus guideline from the ACR ovarian-Adnexal Reporting and Data System committee
AU - Andreotti, Rochelle F.
AU - Timmerman, Dirk
AU - Strachowski, Lori M.
AU - Froyman, Wouter
AU - Benacerraf, Beryl R.
AU - Bennett, Genevieve L.
AU - Bourne, Tom
AU - Brown, Douglas L.
AU - Coleman, Beverly G.
AU - Frates, Mary C.
AU - Goldstein, Steven R.
AU - Hamper, Ulrike M.
AU - Horrow, Mindy M.
AU - Hernanz-Schulman, Marta
AU - Reinhold, Caroline
AU - Rose, Stephen L.
AU - Whitcomb, Brad P.
AU - Wolfman, Wendy L.
AU - Glanc, Phyllis
N1 - Funding Information:
The authors acknowledge the International Ovarian Tumor Analysis (IOTA) Principal Investigators that contributed most of the patients to the IOTA 1-3 study: Lil Valentin, PhD; Antonia C. Testa, PhD; Daniela Fischerova, PhD; Caroline Van Holsbeke, PhD; Luca Savelli, PhD; Dorella Franchi, MD; Elisabeth Epstein, PhD; Artur Czekierdowski, PhD; Stefano Guerriero, PhD; Robert Fruscio, PhD; Francesco G. P. Leone, MD. Additionally, the authors recognize the participation of Blake Gilks, MD, as a member of the O-RADS Committee. We are also grateful for the assistance given by American College of Radiology (ACR) staff: Lauren Hicks, MSHA; Cassandra Vivian-Davis; Dipleen Kaur, MPH; and Lisa Pampillonia, BS. This document was developed with nationally and internationally recognized experts in gynecological imaging, pediatric imaging, gynecological clinical services, and gynecological cancer care, representing the American College of Obstetrics & Gynecology (ACOG), American Institute of Ultrasound in Medicine (AIUM), Canadian Association of Radiologists (CAR), European Society of Gynaecological Oncology (ESGO), European Society of Radiology (ESR), International Ovarian Tumor Analysis Group (IOTA), International Society of Gynecologic Pathologists (ISGYP), International Society of Ultrasound in Obstetrics & Gynecology (ISUOG), Society of Gynecologic Oncology (SGO), Society of Obstetricians & Gynecologists of Canada (SOGC), Society of Pediatric Radiology (SPR), and Society of Radiologists in Ultrasound (SRU). This acknowledgment affirms the ACR's appreciation to ACOG, AIUM, CAR, ESGO, ESR, IOTA, ISGYP, ISUOG, SGO, SOGC, SPR, and SRU but does not imply, infer, or denote approval or endorsement of the document.
PY - 2020
Y1 - 2020
N2 - The Ovarian-Adnexal Reporting and Data System (O-RADS) US risk stratification and management system is designed to provide consistent interpretations, to decrease or eliminate ambiguity in US reports resulting in a higher probability of accuracy in assigning risk of malignancy to ovarian and other adnexal masses, and to provide a management recommendation for each risk category. It was developed by an international multidisciplinary committee sponsored by the American College of Radiology and applies the standardized reporting tool for US based on the 2018 published lexicon of the O-RADS US working group. For risk stratification, the O-RADS US system recommends six categories (O-RADS 0-5), incorporating the range of normal to high risk of malignancy. This unique system represents a collaboration between the pattern-based approach commonly used in North America and the widely used, European-based, algorithmic-style International Ovarian Tumor Analysis (IOTA) Assessment of Different Neoplasias in the Adnexa model system, a risk prediction model that has undergone successful prospective and external validation. The pattern approach relies on a subgroup of the most predictive descriptors in the lexicon based on a retrospective review of evidence prospectively obtained in the IOTA phase 1-3 prospective studies and other supporting studies that assist in differentiating management schemes in a variety of almost certainly benign lesions. With O-RADS US working group consensus, guidelines for management in the different risk categories are proposed. Both systems have been stratified to reach the same risk categories and management strategies regardless of which is initially used. At this time, O-RADS US is the only lexicon and classification system that encompasses all risk categories with their associated management schemes.
AB - The Ovarian-Adnexal Reporting and Data System (O-RADS) US risk stratification and management system is designed to provide consistent interpretations, to decrease or eliminate ambiguity in US reports resulting in a higher probability of accuracy in assigning risk of malignancy to ovarian and other adnexal masses, and to provide a management recommendation for each risk category. It was developed by an international multidisciplinary committee sponsored by the American College of Radiology and applies the standardized reporting tool for US based on the 2018 published lexicon of the O-RADS US working group. For risk stratification, the O-RADS US system recommends six categories (O-RADS 0-5), incorporating the range of normal to high risk of malignancy. This unique system represents a collaboration between the pattern-based approach commonly used in North America and the widely used, European-based, algorithmic-style International Ovarian Tumor Analysis (IOTA) Assessment of Different Neoplasias in the Adnexa model system, a risk prediction model that has undergone successful prospective and external validation. The pattern approach relies on a subgroup of the most predictive descriptors in the lexicon based on a retrospective review of evidence prospectively obtained in the IOTA phase 1-3 prospective studies and other supporting studies that assist in differentiating management schemes in a variety of almost certainly benign lesions. With O-RADS US working group consensus, guidelines for management in the different risk categories are proposed. Both systems have been stratified to reach the same risk categories and management strategies regardless of which is initially used. At this time, O-RADS US is the only lexicon and classification system that encompasses all risk categories with their associated management schemes.
UR - http://www.scopus.com/inward/record.url?scp=85076876723&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85076876723&partnerID=8YFLogxK
U2 - 10.1148/radiol.2019191150
DO - 10.1148/radiol.2019191150
M3 - Article
C2 - 31687921
AN - SCOPUS:85076876723
VL - 294
SP - 168
EP - 185
JO - Radiology
JF - Radiology
SN - 0033-8419
IS - 1
ER -